公开(公告)号：US20190262620A1

公开(公告)日：2019-08-29

申请号：US16409921

申请日：2019-05-13

Applicant: Medtronic, Inc.

Inventor： Hyun J. YOON ,  Wade M. DEMMER ,  Matthew J. HOFFMAN ,  Robert A. BETZOLD ,  Jonathan D. EDMONSON ,  Michael L. ELLINGSON ,  Ben W. HERBERG ,  Juliana E. PRONOVICI ,  James D. REINKE ,  Todd J. SHELDON ,  Paul R. SOLHEIM

IPC: A61N1/37

Abstract: Implantable medical systems enter an exposure mode of operation, either manually via a down linked programming instruction or by automatic detection by the implantable system of exposure to a magnetic disturbance. A controller then determines the appropriate exposure mode by considering various pieces of information including the device type including whether the device has defibrillation capability, pre-exposure mode of therapy including which chambers have been paced, and pre-exposure cardiac activity that is either intrinsic or paced rates. Additional considerations may include determining whether a sensed rate during the exposure mode is physiologic or artificially produced by the magnetic disturbance. When the sensed rate is physiologic, then the controller uses the sensed rate to trigger pacing and otherwise uses asynchronous pacing at a fixed rate.

公开(公告)号：US20200038665A1

公开(公告)日：2020-02-06

申请号：US16600751

申请日：2019-10-14

Applicant: Medtronic, Inc.

Inventor： Hyun J. YOON ,  Wade M. DEMMER ,  Matthew J. HOFFMAN ,  Robert A. BETZOLD ,  Jonathan D. EDMONSON ,  Michael L. ELLINGSON ,  Mark K. ERICKSON ,  Ben W. HERBERG ,  Juliana E. PRONOVICI ,  James D. REINKE ,  Todd J. SHELDON ,  Paul R. SOLHEIM

IPC: A61N1/37 ,  A61N1/368 ,  A61N1/39

Abstract: Implantable medical systems enter an exposure mode of operation, either manually via a down linked programming instruction or by automatic detection by the implantable system of exposure to a magnetic disturbance. A controller then determines the appropriate exposure mode by considering various pieces of information including the device type including whether the device has defibrillation capability, pre-exposure mode of therapy including which chambers have been paced, and pre-exposure cardiac activity that is either intrinsic or paced rates. Additional considerations may include determining whether a sensed rate during the exposure mode is physiologic or artificially produced by the magnetic disturbance. When the sensed rate is physiologic, then the controller uses the sensed rate to trigger pacing and otherwise uses asynchronous pacing at a fixed rate.

公开(公告)号：US20190262604A1

公开(公告)日：2019-08-29

申请号：US16410117

申请日：2019-05-13

Applicant: Medtronic, Inc.

Inventor： Hyun J. YOON ,  Michael L. ELLINGSON ,  Wade M. DEMMER ,  Jonathan D. EDMONSON ,  Matthew J. HOFFMAN ,  Ben W. HERBERG ,  James D. REINKE ,  Todd J. SHELDON ,  Paul R. SOLHEIM ,  Alison M. SEACORD

IPC: A61N1/08 ,  A61N1/37 ,  A61N1/39

Abstract: Implantable medical devices automatically switch from a normal mode of operation to an exposure mode of operation and back to the normal mode of operation. The implantable medical devices may utilize hysteresis timers in order to determine if entry and/or exit criteria for the exposure mode are met. The implantable medical devices may utilize additional considerations for entry to the exposure mode such as a confirmation counter or a moving buffer of sensor values. The implantable medical devices may utilize additional considerations for exiting the exposure mode of operation and returning to the normal mode, such as total time in the exposure mode, patient position, and high voltage source charge time in the case of devices with defibrillation capabilities.